For example, in patients with breast cancer, high GPR68 expression is associated with higher recurrence and mortality rates, which confirms the prognostic potential of GPR68 and provides a basis for individualized treatment plans for patients (Elemam et al., 2022). This evidence concerns the gene GPR68 and breast carcinoma.